Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Fluidigm adds single-cell analysis tools through $207.5mm DVS takeover

Executive Summary

Fluidigm Corp. (microfluidics systems) acquired closely held flow cytometry company DVS Sciences Inc. for $207.5mm, consisting of $125mm in cash (most of which was generated from Fluidigm’s concurrently announced $170mm convertible notes offering) and $82.5mm in Fluidigm shares (approximately 2mm based on the market average).
Deal Industry
  • Research, Analytical Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Payment Includes Cash
    • Payment Includes Stock

Related Companies